ATE231141T1 - (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen - Google Patents
(-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromenInfo
- Publication number
- ATE231141T1 ATE231141T1 AT97909215T AT97909215T ATE231141T1 AT E231141 T1 ATE231141 T1 AT E231141T1 AT 97909215 T AT97909215 T AT 97909215T AT 97909215 T AT97909215 T AT 97909215T AT E231141 T1 ATE231141 T1 AT E231141T1
- Authority
- AT
- Austria
- Prior art keywords
- syndromes
- prevention
- treatment
- related diseases
- estrogen
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK120396 | 1996-10-28 | ||
| PCT/DK1997/000478 WO1998018771A1 (en) | 1996-10-28 | 1997-10-28 | Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE231141T1 true ATE231141T1 (de) | 2003-02-15 |
Family
ID=8102141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97909215T ATE231141T1 (de) | 1996-10-28 | 1997-10-28 | (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0937057B1 (de) |
| JP (1) | JP2001502704A (de) |
| AT (1) | ATE231141T1 (de) |
| AU (1) | AU4699897A (de) |
| CA (1) | CA2270111A1 (de) |
| DE (1) | DE69718500T2 (de) |
| DK (1) | DK0937057T3 (de) |
| ES (1) | ES2191170T3 (de) |
| IL (1) | IL129625A0 (de) |
| NO (1) | NO992007L (de) |
| WO (1) | WO1998018771A1 (de) |
| ZA (1) | ZA979645B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2356986A1 (en) * | 1998-12-30 | 2000-07-06 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| WO2001064665A1 (en) * | 2000-03-01 | 2001-09-07 | Akzo Nobel N.V. | Chroman derivatives as estrogenic compounds |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| EP2407462B1 (de) | 2004-09-21 | 2014-07-30 | Marshall Edwards, Inc. | Substituierte Chromanderivate, Medikamente und therapeutische Verwendung |
| EP2635121B1 (de) | 2010-11-01 | 2020-01-08 | MEI Pharma, Inc. | Isoflavonoidverbindungen und verfahren zur behandlung von krebs |
| SG11201604490SA (en) | 2014-02-07 | 2016-07-28 | Novogen ltd | Functionalised benzopyran compounds and use thereof |
| HUE054998T2 (hu) | 2015-02-02 | 2021-10-28 | Mei Pharma Inc | Kombinációs terápiák emlõrák kezelésében való alkalmazásra |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
| DE1543749A1 (de) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
| US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
| HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
-
1997
- 1997-10-28 JP JP10519937A patent/JP2001502704A/ja active Pending
- 1997-10-28 ES ES97909215T patent/ES2191170T3/es not_active Expired - Lifetime
- 1997-10-28 DK DK97909215T patent/DK0937057T3/da active
- 1997-10-28 ZA ZA9709645A patent/ZA979645B/xx unknown
- 1997-10-28 CA CA002270111A patent/CA2270111A1/en not_active Abandoned
- 1997-10-28 WO PCT/DK1997/000478 patent/WO1998018771A1/en not_active Ceased
- 1997-10-28 AT AT97909215T patent/ATE231141T1/de not_active IP Right Cessation
- 1997-10-28 AU AU46998/97A patent/AU4699897A/en not_active Abandoned
- 1997-10-28 DE DE69718500T patent/DE69718500T2/de not_active Expired - Fee Related
- 1997-10-28 EP EP97909215A patent/EP0937057B1/de not_active Expired - Lifetime
- 1997-10-28 IL IL12962597A patent/IL129625A0/xx unknown
-
1999
- 1999-04-27 NO NO992007A patent/NO992007L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA979645B (en) | 1998-04-28 |
| ES2191170T3 (es) | 2003-09-01 |
| WO1998018771A1 (en) | 1998-05-07 |
| EP0937057A1 (de) | 1999-08-25 |
| CA2270111A1 (en) | 1998-05-07 |
| AU4699897A (en) | 1998-05-22 |
| NO992007D0 (no) | 1999-04-27 |
| IL129625A0 (en) | 2000-02-29 |
| DK0937057T3 (da) | 2003-05-05 |
| DE69718500D1 (de) | 2003-02-20 |
| DE69718500T2 (de) | 2003-11-27 |
| JP2001502704A (ja) | 2001-02-27 |
| NO992007L (no) | 1999-06-25 |
| EP0937057B1 (de) | 2003-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE192649T1 (de) | Stereochemische wortmanninderivate | |
| AU2610799A (en) | Glp-1 derivatives with helix-content exceeding 25 per cent, forming partially structured micellar-like aggregates | |
| NO20006645D0 (no) | Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme | |
| AU2843689A (en) | 2-(2-hydroxy-3-phenoxypropylamino) ethylphenoxymethyl compounds | |
| DK0807633T3 (da) | Hidtil ukendte 2,3-disubstituerede-(5,6)-heteroarylkondenserede pyrimidin-4-oner | |
| ATE237633T1 (de) | Analogen des keratinozytenwachstumfaktors | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| ATE229518T1 (de) | Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen | |
| UA35607C2 (uk) | Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання | |
| DK0736029T3 (da) | Antikonvulsive pseudofructopyranosesulfamater | |
| BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
| ATE229519T1 (de) | Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromen | |
| ATE231141T1 (de) | (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| NO992010L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| NO992008L (no) | Nye (+)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| NO992005L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| NO992009L (no) | Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| EP0386920A3 (de) | 2-Hydroxy-3-thienyloxypropylamin-Derivate | |
| NO992002L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| RU94046453A (ru) | Производные изосерина, способ их получения, фармкомпозиция и способ лечения | |
| NO992004L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| DE69428127D1 (de) | Schädlingsbekämpfungsmittel | |
| DE69916103D1 (de) | 3-alkoxylbenzylaminderivate und ihre verwendung als arzneimittel zur behandlung von schizophrenie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0937057 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |